Background {#Sec1}
==========

Obesity, as a major public health concern, has increased prevalence worldwide \[[@CR1], [@CR2]\]. According to World Health Organization (WHO) report, over 650 million adults across the world are obese. Available data have also shown a risen rate of obesity among the Iranian population over the last three decades. Recently, it has been estimated that 21.7% of Iranian adults are obese \[[@CR3]\]. A large body of evidence has shown that obesity is a strong risk factor for various chronic diseases including cardiovascular disease, diabetes, stroke and certain types of cancers \[[@CR4]\]. Additionally, obesity, in all age groups, is related to more adverse cardio-metabolic risk factors, including hypertension, hypertriglyceridemia, and insulin resistance \[[@CR5]\].

Since obesity is a chronic and complex condition, genetic and environmental factors, and their interaction play a critical role in prevention and development of obesity \[[@CR6]\]. Diet, as a major lifestyle factor, plays a critical role in the prevention and development of obesity and its consequence non-communicable diseases (NCDs) \[[@CR6], [@CR7]\]. Traditional researches of diet and chronic diseases have usually focused on single foods and macro- and micronutrients without considering synergistic effect of highly correlated nutrients and interactions between food components \[[@CR8]\]. Many investigators have suggested index-based dietary pattern approach as a strong and more informative tool for evaluating diet-disease associations \[[@CR9]\].

Diet Quality Index-International (DQI-I), one of the predefined diet quality indexes, is developed to make comparisons of diet quality among countries experiencing different stages of the nutrition transition \[[@CR10]\]. Although there are only few studies have assessed the association between DQI-I and obesity, the finding these researches are conflicting \[[@CR11]--[@CR13]\]. Additionally, Healthy Eating Index (HEI), as one of the most popular diet quality indicator in nutrition research, was constructed by United States Department of Agriculture to measure alignment with Dietary Guidelines for Americans (DGA) \[[@CR14]\]. HEI-2015, the most recent updated version, reflects the 2015--2020 DGA by employing a density-based approach \[[@CR15]\]. Prior versions of HEI have found to be inversely related to major chronic diseases such as cardiovascular disease, cancer, and Type 2 diabetes \[[@CR16]\]. However, the results of previous studies regarding the association between this index and obesity are not consistent \[[@CR11]\]. Moreover, there are scarce studies on the above association in developing countries \[[@CR9]\]. On the other hand, the applicability of latest version of HEI (HEI-2015) in many chronic disease especially obesity has not yet assessed. Hence, it is required to examine efficacy of this new HEI score in developing nations.

Beside diet, genetic factors can also influence on susceptibility to obesity and its comorbidities. The melanocortin-4 receptor (MC4R), a plasma membrane G protein-coupled receptor, plays a central role in regulating appetite and energy homeostasis \[[@CR17]\]. Activity of this receptor is regulated by endogenous neuropeptides including: alpha -melanocyte stimulating hormone (α-MSH) and agouti-related protein (AGRP) \[[@CR18]\]. Previous evidence of animal studies has revealed that any defect and disruption in MC4R gene may be lead to obesity-related phenotypes \[[@CR19]\]. A large-scale meta-analysis of seven genome-wide association studies (GWAS) in 2008 reported MC4R as the second association signal for common obesity \[[@CR20]\]. Loos et al. \[[@CR20]\] in this study found a single nucleotide polymorphism (SNP) near MC4R (rs17782313), located 188 kb downstream of the MC4R, which was strongly related to obesity in adults and children. Subsequently, the association between rs17782313-SNP and different obesity-related phenotypes has been investigated among populations with various ethnicities \[[@CR21], [@CR22]\]. However, some of the studies have found no association between rs17782313 and obesity-related cardio-metabolic traits \[[@CR23]--[@CR25]\]. This observed inconsistency might be due to the role of lifestyle factors specially diet in modulation of the effects of MC4R gene variation. On the other hand, scientific evidence has indicated that response to dietary modifications in treatment of obesity and its-related cardio-metabolic risk factors differs in various communities with different genetic structures \[[@CR26]\]. So, it seems that interaction between diet and genetic susceptibility may explain this reciprocal effect, and these interactions may play an important role in development of obesity and its comorbidities \[[@CR27]\]. So far, there is no study regarding the effect of the interaction between diet quality indices and rs17782313 polymorphism on cardio-metabolic risk factors and hypothalamic hormones (α-MSH and AgRP). Thus, the first aim of current study was to assess the association between genotypes of rs17782313 and cardio-metabolic risk factors and also diet quality indices (HEI-2015, DQI-I). Second, it was aimed to examine potential interactions between genotypes of rs17782313 and diet quality indices on cardio-metabolic risk factors and hypothalamic hormones in a group of obese Iranian population.

Methods {#Sec2}
=======

Subjects {#Sec3}
--------

The present research is a cross-sectional study carried out in Tabriz, Iran. Target population was 188 apparently healthy obese adults (92 males and 96 females) aged 20--50 years that were recruited using simple random sampling. The advertisements that provided general information about inclusion criteria (age 20 to 50 years, good health and obesity (body mass index (BMI) ≥ 30 kg/m^2^)) were used for recruiting eligible participants. Subjects were excluded if the following applied: pregnancy, lactation, and menopause, having any evidence of chronic disease such as hypertension, hyperlipidemia, cardio-vascular diseases, diabetes, hepatic disorders, renal disease, and cancer, or taking any medications effective for weight loss such as loop diuretics or corticosteroids, or antidepressants. Moreover, people taking lipid-lowering (e.g. statins) and antihypertensive medications were excluded. All protocols of this study were approved by Ethical Committee of the Tabriz University of Medical Sciences (registration code IR.TBZMED.REC.768). All of the subjects completed a written informed consent before participation in the study.

Dietary assessment and calculation of dietary scores {#Sec4}
----------------------------------------------------

Usual dietary intake was assessed by trained dietitians using a validated and reliable 147-item semi-quantitative food frequency questionnaire (FFQ) \[[@CR28], [@CR29]\]. Participants were asked to report frequency and amount of each food item consumed on a daily, weekly, monthly or yearly basis. Then, portion sizes of consumed foods were converted to gram using household measures \[[@CR30]\]. Daily energy and nutrient intake were analyzed using Iranian Food Composition Table (FCT) \[[@CR31]\] and complemented with the United States Department of Agriculture FCT \[[@CR32]\].

HEI-2015 {#Sec5}
--------

HEI-2015, a measure of conformance to the 2015--2020 DGA, uses an energy density approach to scoring most components (i.e., scores per 1000 cal) \[[@CR15]\]. This measure is made up of 13 components, 9 adequacy and 4 moderation components with a total score of 100 points. Total vegetables, total fruits (fruit, fruit juice and canned fruit), whole fruits (fruits except fruit juice), seafood and plant proteins, greens and beans, and total protein foods, scored 5 and 0 in the highest and lowest consumption, respectively. Other three adequacy components including whole grains, dairy and fatty acids were scored from 0 to 10, where 10 represents the highest consumption and 0 shows the lowest consumption. Moderation components include refined grains, sodium, added sugars, and saturated fats were scored in reverse (score 10 for the lowest consumption and score 0 for the highest consumption). It should be noted that the intermediate scores were computed proportionally. Higher total HEI-2015 scores reflecting a healthful diet and greater adherence to dietary guidelines.

DQI-I {#Sec6}
-----

The Diet Quality Index -- International (DQI-I) was constructed based on Kim et al's method \[[@CR10]\]. This indicator is constructed based on four categories of a high-quality diet including: variety, adequacy, moderation and overall balance. Total DQI-I score was computed by summing the scores of these categories, ranging from 0 to 100. There were sub-components for each of these categories. Dietary variety scores included diversity in food group and protein sources (20 points). Adequacy scores were adequate intake of fruits, vegetables, grains, fiber, protein, iron, vitamin C and calcium (40 points).

Moderation scores included total fat, saturated fat, cholesterol, sodium and empty calorie foods (30 points) and lastly overall balance score which capture balance of macronutrient and fatty acid ratios (10 points). A higher DQI-I score mean better diet quality.

Demographic, anthropometric and blood pressure measures {#Sec7}
-------------------------------------------------------

Basic information including: age, gender, marital status, smoking and medical history were collected using standard questionnaires. Socioeconomic status (SES) was assessed through collecting information about occupational position, educational status, family size and house ownership as individual indicators. Then, total score was calculated. Information on Physical activity was evaluated using a self-administered short form of the International Physical Activity Questionnaire completed \[[@CR33]\].

Body weight was measured with a Seca scale (Seca, Germany) to the nearest 100 g, while participants were minimally clothed without shoes. Height was also measured using a tape measure with a precision of 0.1 cm, in a standing position without shoes. Waist circumference (WC) was determined at narrowest area below the rib cage and above the umbilicus using a stretch-resistant tape measure to the nearest 0.1 cm over light clothing without applying any pressure to the body. Measurement of blood pressure was performed using a standardized mercury sphygmomanometer, after 15 min rest in a sitting position on chair. This measurement was conducted twice and the mean was considered as participant's blood pressure.

Mental health assessment {#Sec8}
------------------------

Self-administered the depression, Anxiety and Stress Scale 21 (DASS-21) questionnaire was employed for the mental health assessment component. The reliability (Cronbach's alpha: 0.77, 0.79 and 0.78 for depression, anxiety and stress, respectively) and validity of this scale have previously been assessed among Iranian population \[[@CR34], [@CR35]\]. Each of the three scales, including depression, anxiety and stress has seven items and each answer is rated on a 4-point Likert scale, ranging from zero ("did not apply to me at all") to 3 ("applied to me very much or most of the time"). A total score for each scale was determined by summing the relevant items scores. Based on the obtained overall score of each scale, subjects were classified into 5 categories: normal, mild, moderate, severe and extremely severe. Higher score of each three scale reflected greater degree of mood disruption.

Appetite measurements {#Sec9}
---------------------

Appetite measurement was carried out using a 100-mm, visual analogue scale (VAS). VAS is a validated questionnaire and includes questions about feelings of hunger, satiation, fullness, prospective food consumption and the desire to eat something sweet, salty, or fat \[[@CR36]\]. Subjects were requested to complete this questionnaire by making vertical mark on a 100 mm horizontal line for each question. VAS scores were calculated by measuring the distance from the left side of the line to the mark.

Laboratory assessments {#Sec10}
----------------------

After an overnight fast, venous blood samples (10 ml) were taken from all subjects. These samples were centrifuged (10 min at 4500 rpm, 4 °C) to separate plasma and serum and then aliquoted and frozen at 80 C° until assay. Measurements of serum glucose, triglyceride (TG), total cholesterol and high-density lipoprotein cholesterol (HDL-C) were performed using a commercial kit (Pars Azmoon, Tehran, Iran).

Low-density lipoprotein cholesterol (LDL-C) concentration was calculated by the Friedewald equation \[[@CR37]\]. Commercially available enzyme-linked immunosorbent assay (ELISA) kits (Bioassay Technology Laboratory, Shanghai Korean Biotech, Shanghai City, China) were used to detect plasma α-MSH and AgRP levels and also serum insulin concentration. The minimum level of detection of α-MSH and AgRP levels were 5.07 ng/L and 1.03 pg/ml, respectively. All these biochemical measurements were conducted according to the manufacturer's protocol.

Homeostasis model assessment-insulin resistance index (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI), the most used indices for evaluating insulin sensitivity, were calculated using standard formula \[[@CR38], [@CR39]\]. Atherogenic index of plasma (AIP) was calculated as Lg~10~ (serum triglycerides/serum HDL-C).

Genotyping {#Sec11}
----------

Genomic DNA was extracted from whole blood samples using a standard phenol/chloroform method. Genotyping of the single nucleotide polymorphisms MC4R (rs17782313) was conducted by Polymerase Chain Reaction (PCR) with subsequent restriction fragment length polymorphism assay. PCR amplification of rs17782313 was carried out using designed following primers: forward, 5′ AAGTTCTACCTACCATGTTCTTGG3′ and reverse, 5′ TTCCCCCTGAAGCTTTTCTTGTCATTTTGAT 3′ (Macro-gene, Korea). The volume of each PCR reaction was 20 μl containing 200 ng of DNA, 0.5 μmol of each primer, 10 μl of Taq DNA Polymerase 2 × MasterMix (Ampliqon, Germany). PCR cycles was optimized with an initial denaturation at 95 °C for 2 min, denaturation at 95 °C for 30 s (35 cycles), annealing at 58 °C for 30 s and 30 s of extension at 72 °C. An additional extension occurred at 72 °C for 5 min. PCR products were digested using BclI (Fermentas, Germany) enzyme digestion. Digestion solution (7 μl of PCR product, 0.5 μl of BclI 10 U/μl and 2 μl of 10× restriction G-buffer) was incubated at 56 °C over-night. After that, electrophoresis of the digested PCR products was carried out on 2% agarose gel. To visualize DNA fragments, gels were stained with green viewer (Pars Tous, Iran) on a Gel Doc-system (U.V.P Company, Cambridge, UK). T allele was appeared as fragments with length of 30 and 107 bp. C allele was also considered as a 137 bp fragment.

Statistical analysis {#Sec12}
--------------------

Normal distribution of data was checked by descriptive measures such as coefficients of skewness and kurtosis, mean and standard deviation \[[@CR40]\]. The data were presented as frequency (%) for categorical variables and as mean ± SD for normally distributed continuous variables. Data that were not normally distributed were expressed as median (25th and 75th percentile). Continuous variables including glucose, HOMA-IR, insulin, α-MSH and AgRP that were not normally distributed were log-transformed for analyses that required normal data. The relationships between general characteristics of participants and rs17782313 genotypes were analyzed using the analysis of variance (ANOVA) and chi-square tests. Sex-stratified analysis of covariance (ANCOVA) was used to compare clinical and biochemical parameters between three groups of genotypes by adjusting for the confounding effects of age, physical activity and WC. The association between diet quality indices and rs17782313 genotypes were evaluated by multivariate multinomial logistic regression in different models. Sex-stratified analysis of covariance (ANCOVA) multivariate interaction models using the General Linear Model procedures was used to test the interactions between MC4R polymorphism (rs17782313) and diet quality indices in relation to cardio-metabolic risk factors. After adjusting for confounding factors (age, physical activity and WC), significant interactions were presented as graph to help their illustration. In all interaction analyses, homozygous wild-type group was considered as reference. All statistical analyses were done using Statistical Package for Social Sciences (SPSS, Inc., Chicago, IL, version 21). A *P* value ≤0.05 was considered statistically significant.

Results {#Sec13}
=======

Demographic, genetic and mental characteristics of participants across MC4R rs17782313 genotype are presented in Table [1](#Tab1){ref-type="table"}. There was no significant difference regarding anthropometric and socio-demographic variables and mental health parameters across MC4R rs17782313 genotype. The C-allele of rs17782313 was minor allele and had a frequency of 37% and accordingly T-allele was major allele. Table 1General characteristics of participants according to MC4R rs17782313 genotypesGenotypeTTTCCC*P*-value\*Gender0.157 Men, n (%)35 (50.7)23 (33.4)11 (15.9) Women, n (%)28 (38.9)28 (38.9)16 (22.2)Age (y)38.9 (7.8)38.1 (7.3)37.2 (7.6)0.606WC108.9 (10.0)108.8 (9.6)105.4 (8.2)0.232BMI (kg/m^2)^34.5 (3.6)34.4 (3.2)34.3 (3.4)0.958Physical activity level, n (%)0.253 Low29 (40.8)28 (39.4)14 (19.7) Moderate12 (36.4)15 (45.5)6 (18.2) High22 (59.5)8 (21.6)7 (18.9)Marital status, n (%)0.776 Married53 (43.8)45 (37.2)23 (19.0) Single10 (50.0)6 (30.0)4 (20.0) SES score10.3 (2.3)9.8 (2.5)9.2 (2.6)0.107Depression, n (%)0.703 Normal30 (47.6)21 (33.3)12 (19.1) Mild8 (36.4)12 (54.5)2 (9.1) Moderate16 (47.0)9 (26.5)9 (26.5) Severe5 (50.0)2 (20.0)3 (30.0) Extremely severe4 (33.3)7 (58.4)1 (8.3)Anxiety, n (%)0.417 Normal23 (45.1)20 (39.2)8 (15.7) Mild6 (46.2)5 (38.4)2 (15.4) Moderate17 (47.2)13 (36.1)6 (16.7) Severe7 (43.7)4 (25.0)5 (31.3) Extremely severe10 (40.0)9 (36.0)6 (24.0)Stress, n (%)0.343 Normal25 (43.9)22 (38.6)10 (17.5) Mild9 (36.0)8 (32.0)8 (32.0) Moderate16 (45.7)13 (37.1)6 (17.2) Severe9 (50.0)6 (33.3)3 (16.7) Extremely severe4 (66.7)2 (33.3)0 (0.0) Appetite33.1 (10.1)33.2 (8.4)34.4 (7.5)0.824\*Analysis of variance for continuous variables and χ^2^ test for categorical variables. Data are Mean ± SD*Abbreviations*: *BMI* body mass index, *WC* waist circumference, *SES* socio-economic status

Table [2](#Tab2){ref-type="table"} shows sex-stratified analysis for the association between clinical and biochemical parameters and MC4R rs17782313 polymorphisms. In men, being in the CC genotype group was associated with higher serum glucose concentrations (*P* = 0.016). This association remained significant even after adjustment for age, WC and physical activity (*P* = 0.012). Moreover, men in CC genotype group showed lower plasma AgRP level than those in TT and CT genotype groups, either in the crude (*P* = 0.025) or the adjusted (*P* = 0.046). However, no statistical significant difference was seen regarding biochemical parameters across MC4R rs17782313 genotypes among women. Sex-stratified analysis for the association between dietary indices and rs17782313 genotypes are presented in Table [3](#Tab3){ref-type="table"}. In female subjects, there was an inverse association between HEI score and odds of having CC genotype when compared to homozygote group with major allele (OR, 0.87; 95% CI, 0.78--0.96). This association remained consistently significant even after adjusting for various potential confounders in multi-adjusted models (OR, 0.88; 95% CI, 0.78--0.98). There was no association between dietary quality indices (HEI and DQI-I) and rs17782313 genotypes; neither in crude nor in multi-adjusted models in men. Sex-stratified interaction analysis was performed to assess modification effects of dietary quality indices (HEI and DQI-I) on the association between MC4R variant and lipid profile and glycemic indices. Significant interactions among men and women are illustrated in Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}, respectively. Among women, no gene-diet interaction was found except for HEI and rs17782313 in associations with LDL-C levels (P-interaction = 0.044). This interaction remained statistically significant after adjusting for age, physical activity and WC (P ~Interaction~ = 0.040). In particular, the CT-genotype carriers who placed in the second tertile of HEI had the highest LDL-C level (*P* \< 0.05). On the other hand, we found a gene--diet interaction between rs17782313 genotypes and both HEI (P ~Interaction~ = 0.020) and DQI-I (P ~Interaction~ = 0.006) for glucose level in male subjects. Such that subjects with the homozygous minor allele genotype were characterized by higher serum glucose concentrations when had lowest adhere to HEI and DQI-I. Furthermore, a significant interaction was detected between DQI-I and rs17782313 for SBP (P ~Interaction~ = 0.047) and also DBP (P ~Interaction~ = 0.006) after controlling for potential confounder. The highest mean of SBP and DBP was observed in CC genotype group in the first tertile of DQI-I, compared to other tertiles of this index (*P* \< 0.05). No significant interaction was found between MC4R rs17782313 polymorphisms and diet quality indices (HEI and DQI-I) on hypothalamic hormones in both men and women. Table 2Comparison of clinical and laboratory parameters of participants according to MC4R rs17782313 genotypesWomenMenTTTCCCP\*P\*\*TTTCCCP\*P\*\*LDL-C, (mg/dl)126.9 (29.60)118.56 (31.06)108.91 (28.09)0.1610.153120.46 (26.31)118.30 (30.01)108.58 (28.41)0.4710.533HDL, (mg/dl)48.46 (10.27)46.37 (10.19)49.44 (6.46)0.5490.72041.11 (6.64)43.35 (9.22)44.45 (9.61)0.3880.421Cholesterol, (mg/dl)197.71 (33.88)185.74 (35.45)177.75 (28.62)0.1460.120188.4 (28.39)187.78 (31.20)184.09 (43.36)0.9180.953TG, (mg/dl)111.75 (46.33)104.07 (41.84)97 (35.23)0.5300.430122 (80, 169)121 (90, 164)123 (90, 184)0.9310.873AIP−0.0226 (0.240)−0.032 (0.230)−0.087 (0.175)0.6310.6080.11(0.23)0.09 (0.25)0.12 (0.29)0.9070.866Glucose, (mg/dl)92.00 (87.25, 97.00)91 (81, 101)90.00 (85.25, 94.00)0.8340.67593 (87, 102)90 (83, 97)100 (87, 159)**0.0160.012**Insulin, U/mL13.55 (9.28, 24.10)19.60 (9.70, 27.30)13.75 (9.00, 16.23)0.3060.27811.40 (8.90, 17.20)10.90 (8.40, 19.50)11.00 (9.30, 24.80)0.5070.439HOMA-IR^a^3.17 (2.00, 5.56)4.82 (2.01, 6.58)3.15 (2.09, 3.56)0.4090.3952.70 (1.78, 4.13)2.61 (1.87, 5.04)4.16 (2.30, 6.70)0.0770.061QUICKI0.32 (0.03)0.32 (0.04)0.33 (0.03)0.4660.3450.33 (0.03)0.33 (0.03)0.31 (0.03)0.1260.104SBP (mmHg)111.86(14.48)116.64 (16.85)111.19 (14.40)0.4040.716117.71 (12.45)118.70 (15.83)115.4 (13.68)0.8160.966DBP (mmHg)76.5 (10.11)78.82 (14.38)75.5 (11.68)0.6440.81077 (10.79)78.26 (10.93)74.09 (11.36)0.5840.664α-MSH (ng/L)2.16 (2.12--2.20)2.26 (2.17--2.35)2.26 (2.11--2.41)0.1530.2592.29 (2.20--2.37)2.39 (2.25--2.52)2.18 (2.09--2.27)0.1050.175AgRP (pg/ml)1.33 (1.29--1.37)1.43 (1.36--1.51)1.41 (1.29--1.53)0.0820.1761.49 (1.42--1.57)1.57 (1.46--1.68)1.33 (1.25--1.41)**0.0250.046**Data are presented as, mean (SD) or geometric mean (95% CI). Analysis of variance for continuous variables and χ^2^ test for categorical variables. \**P* values based on One-Way ANOVA, \*\**P* values adjusted for age, physical activity and WC *Abbreviations*: *HOMA-IR* homeostasis model assessment of insulin resistance, *LDL-C* low density lipoprotein cholesterol, *HDL* high-density lipoprotein, *SBP* systolic blood pressure, *DBP* diastolic blood pressure, *TG* triglyceride, *QUICKI* quantitative insulin sensitivity check index, *AgRP* agouti-related protein, *α-MSH* alpha melanocyte stimulating hormone, *AIP* athrogenic indx of plasma. Bold values provide significant treshold as *P \<0.05*Table 3Odd's ratio (OR) and confidence interval (CI) for the association between dietary quality indices and MC4R rs17782313 genotypesTTWomenCCTTMenCCTCTCHEI. Total score Crude1(Ref.)0.99 (0.93--1.06)**0.87 (0.78--0.9**6)1(Ref.)1.05 (0.97--1.13)1.02 (0.93--1.11) Model 1\*1(Ref.)1.00 (0.93--1.08)**0.86 (0.78--0.98)**1(Ref.)1.06 (0.98--1.15)1.02 (0.93--1.13) Model 2\*\*1(Ref.)1.01 (0.93--1.09)**0.88 (0.78--0.98)**1(Ref.)1.06 (0.98--1.14)1.02 (0.93--1.13)DQI.I. Total score Crude1(Ref.)1.00 (0.94--1.06)0.94 (0.87--1.01)1(Ref.)1.05 (0.98--1.13)0.97 (0.89--1.07) Model 11(Ref.)0.99 (0.93--1.06)0.94 (0.87--1.02)1(Ref.)1.06 (0.99--1.15)0.98 (0.89--1.08) Model 21(Ref.)1.00 (0.93--1.07)0.94 (0.87--1.02)1(Ref.)1.06 (0.99--1.14)0.98 (0.89--1.08)The multivariate multinomial logistic regression was used for estimation of ORs and confidence interval (CI). \*Adjusted for age, physical activity and WC. \*\* Additionally adjusted for stress. Bold values provide significant treshold as *P \< 0.05*Fig. 1Interaction between the MC4R rs17782313 polymorphisms and HEI-2015 on serum concentrations of glucose among men (**a**), interaction between the rs17782313 SNP and DQI-I on serum concentrations of glucose (**b**), Systolic blood pressure (**c**) and Diastolic blood pressure (**d**) among men. *p*.values of interactions were adjusted for age, WC and physical activity. The bars indicate mean. Error bars: SE of means.Fig. 2Interaction between the rs17782313 SNP and HEI-2015 on serum concentrations of LDL-Cholesterol among women (**e**). *p*.values of interactions were adjusted for age, WC and physical activity. The bars indicate mean. Error bars: SE of means.

Discussion {#Sec14}
==========

To our knowledge, our study is the first to report the interaction between MC4R rs17782313 polymorphisms and diet quality indices on cardio-metabolic traits. In the present study, we found that adherence to the HEI modified the effects of MC4R rs17782313 polymorphisms (rs17782313) on levels of LDL-C in women and glucose in men. Among female group, rare allele heterozygotes of rs17782313 had highest mean of LDL-C concentration when placed in second tertile of HEI. Furthermore, in male group, a gene-diet interaction was detected between DQI-I and MC4R rs17782313 on glucose level, SBP and DBP. Statistical adjustment for age, physical activity and WC did not change the statistical significance of these gene--diet interactions in both men and women. Among male homozygous carriers of the risk allele, those with lowest adherence to HEI and DQI-I had highest glucose concentrations. Another novel finding of our study was the inverse association between adherence to the HEI and chance of having CC genotype among female group. In addition, minor homozygote carriers of rs17782313 had lower adjusted means of AgRP levels compared with other genotypes (TT and TC).

Various range of minor allele frequency of rs17782313 polymorphism has been reported in different populations from 14% in Asians to 28% in Europeans. However, current study showed a frequency of 37% in Iranian population. Despite interactions between MC4R genes and dietary factors on obesity and other metabolic traits have been investigated in several studies \[[@CR25], [@CR41]\], significant results have been reported only in limited number of investigations \[[@CR42]\]. In this regard, Ortega-Azorín et al. found that adherence to the Mediterranean dietary pattern (MedDiet) could modify genetic susceptibility to diabetes \[[@CR43]\]. In that study, CC-genotype carriers of the MC4R rs17782313 with low adherence to the MedDiet had a higher risk of Type 2 diabetes. To the best of our knowledge, specific interaction of variant rs17782313 gene with dietary intakes on cardio-metabolic risk factors is unknown. In the present research, among males with susceptible genotypes, individuals with poor adherence to HEI and DQI-I exhibited a higher SBP, DBP and glucose concentration. Our finding in this regard are supported by animal studies in which homozygous mutated mice exposed with high fat diet, exhibited hyperphagia and weight gain compared with wild-type mice \[[@CR44]\]. Moreover, finding of a cohort study confirmed that improving adherence to diet quality represented by higher scores of alternate healthy eating index (AHEI)-2010 and dietary approach to stop hypertension (DASH) could attenuate the genetic association with weight gain particularly in subjects at high genetic risk for obesity \[[@CR45]\]. On the other hand, our data indicated among female group, CT-genotype carriers who placed in the second tertile of HEI had the highest LDL-C concentrations. Gender-dependent differences regard to the association between rs17782313 and obesity-related traits have previously recognized \[[@CR46]\]. The reason for this discrepancy between men and women is unclear but might be related to difference in hormonal status and regional depots of adipose tissue \[[@CR47]\]. There is increasing evidence that polymorphism of rs17782313 (minor C allele) is related to some of cardio-metabolic risk factors such as hypertriglyceridemia \[[@CR48]\], low HDL-cholesterol \[[@CR49]\] and high LDL and total cholesterol \[[@CR24]\]. Likewise, we found the homozygous males for the minor allele (C) had higher adjusted means of serum glucose levels compared with the other genotypes (TT and TC). Our finding in this regard was in line with previous observational studies that SNP rs17782313 was significantly associated with insulin resistance \[[@CR50]\] and enhanced risk of diabetes \[[@CR51]\]. In the present study, HEI score was negatively associated with polymorphism of rs17782313 (CC genotype) among female group. Similarly, there is evidence that indicate rs17782313 SNP of MC4R gene influence on dietary intake parameters \[[@CR51]\]. For example, Qi et al. in a large cohort study indicated that rs17782313 variant was associated with higher intakes of total energy and dietary fat \[[@CR51]\]. Nevertheless, the evidence from other human investigations in this regard is inconsistent \[[@CR52]\]. In the current study, adherence to healthy dietary patterns, which consider the effects of whole diet instead of focusing on single foods and macro- and micronutrients in isolation, were assessed by diet quality scores. Even though the precise mechanisms behind these observed interactions remain unknown, there is considerable evidence that these diet quality indices (HEI and DQI-I) protects against major diet-dependent chronic diseases \[[@CR53], [@CR54]\]. Hence, it is not surprising that lower adherence to these diet quality indices can promote effects of greater genetic susceptibility to cardio-metabolic risk factors. The favorable effects of these indices can be attributed to healthy choice such as vegetables, fruits, whole grains, sea food and plant proteins and more emphasize on polyunsaturated-to saturated fat ratio \[[@CR10], [@CR54]\]. In this regard, emerging researches demonstrated the inverse associations of fruit, vegetables and diet-related chronic diseases \[[@CR55]\].

Although not much is known about the association between α-MSH, AgRP and MC4R polymorphisms, present investigation showed that homozygous male for the minor allele (C) had lower levels of AgRP than other genotypes. Previous human studies that have investigated plasma AgRP and α-MSH concentration have reported equivocal results \[[@CR56]--[@CR58]\]. However, most of these studies have shown that both plasma α-MSH and AgRP levels increase in obese adult subjects \[[@CR56], [@CR57]\]. Evidence had indicated that any alteration in expression of these orexigenic and anorexigenic peptides (α-MSH and AgRP) may play a potential role in energy homeostasis, food intake and development of obesity \[[@CR59]\].

Several limitations of the current study should also be addressed; firstly, due to the cross-sectional nature of this study, causality cannot be inferred. Nevertheless, these results can provide hypothesis for prospective studies to evaluate and confirm true causal relation. Secondly, since small sample size may limit statistical power, the results of present study with relatively small sample size should be interpreted with caution until replicated in large longitudinal studies. Thirdly, under-reporting of dietary intakes that are commonly observed in obese individuals, may lead to potential bias and null results \[[@CR60]\]. However, subjects with extreme dietary intake values were not included in the analysis. On the other hand, current study as the same as other observational studies is prone to residual confounding due to unknown or unmeasured confounders \[[@CR61]\]. Fourthly, we did not have information regarding other modifiable factors such as meal and snacking patterns and dietary habits that may be effective on observed associations. Lastly, this research was carried out in Tabriz, one of the major cities in Iran with a unique culture and dietary intake, so results may not be generalizable to all Iranians and it need to be replicated in other populations. Despite limitations discussed above, this is the first attempt to study the interaction between MC4R rs17782313 polymorphisms and diet quality indices on cardio-metabolic traits, according to our knowledge. Identification of these gene-diet interactions could be crucial in planning appropriate personalized nutritional advice for the prevention and management of obesity and its-related consequences. Another major strengths of present study was use of a reliable \[[@CR29]\] and validated \[[@CR28]\] FFQ to collect dietary information.

Conclusions {#Sec15}
===========

In conclusion, the finding of present study showed for the first time a statistically significant gene-diet interaction of the MC4R rs17782313 with adherence to the dietary quality indices (HEI and DQI-I) on some of cardio-metabolic risk factors in both genders. In sum, in male group, when adherence to these indices was low, the obesity risk allele (CC) was associated with higher fasting glucose level, SBP and DBP. On the other hand, in female group, medium adherence to HEI by rare allele heterozygotes of rs17782313 increased the risk of having higher LDL-C level. The results of our study should be confirmed in large prospective studies.
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